AKYA Akoya Biosciences
- 2.900
- -1.220-29.61%
- 2.900
- 0.0000.00%
Akoya Biosciences News
Akoya Biosciences | 10-Q: Quarterly report
JAN, MTC and PROK Among Mid-day Movers
Akoya Biosciences Price Target Cut to $6.00/Share From $10.00 by Canaccord Genuity
Akoya Biosciences Price Target Cut to $6.00/Share From $10.00 by Canaccord Genuity
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results.The e-commerce giant reported fiscal fourth-quarter 2023 reven
Akoya Biosciences Is Maintained at Buy by BTIG
Akoya Biosciences Is Maintained at Buy by BTIG
Akoya BioSciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results and Cut Its FY24 Revenue Guidance Below Estimates. Also, BTIG Maintained a Buy Rating on the Stock but Lowered Its Price Target From $9 to $6.
Akoya BioSciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results and Cut Its FY24 Revenue Guidance Below Estimates. Also, BTIG Maintained a Buy Rating on
BTIG: Maintains Akoya Biosciences (AKYA.US) rating, adjusted from buy to buy rating, and adjusted target price from $9.00 to $6.00.
BTIG: Maintains Akoya Biosciences (AKYA.US) rating, adjusted from buy to buy rating, and adjusted target price from $9.00 to $6.00.
BTIG Maintains Buy on Akoya Biosciences, Lowers Price Target to $6
BTIG analyst Mark Massaro maintains Akoya Biosciences with a Buy and lowers the price target from $9 to $6.
Akoya Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 98.02% BTIG $9 → $6 Maintains Buy 03/06/2024 230.03% JP Morgan $12 → $10 Maintains Overweight 0
Cutera, Inotiv, Treace Medical Concepts Among Healthcare Movers
Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Ahead of Powell Speech
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) advanced marginally by 0.03% while the actively traded Invesco QQQ Trust (QQQ) was down 0.01% in Tuesday's premarket activity, ahead
Top Premarket Decliners
Augmedix (AUGX) shares plunged 38% in recent Tuesday premarket activity after Evercore ISI downgraded the stock to in line from outperform. Inotiv (NOTV) stock fell 34% after Jefferies downgraded it t
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCareCloud (NASDAQ:CCLDO) stock moved upwards by 46.1% to $15.5 during Tuesday's pre-market session. Syra Health (NASDAQ:SYRA) shares increased by 33.08% to $1.77. The market value of their outs
Piper Sandler Reaffirms Their Buy Rating on Akoya Biosciences (AKYA)
Changes in US stocks 丨 Akoya fell 20.6% before the market, and Q1 losses exceeded expectations, and full-year revenue guidance fell short of expectations
Greenhui, May 14 | Space biology company Akoya (AKYA.US) fell 20.6% to $3.27 before the market. The company lost $23.5 million in the first quarter compared to an expected loss of $14.3 million. In the same period last year, Akoya lost $18.8 million. Akoya's revenue of $18.4 million was lower than analysts' estimates of $24.3 million, down from $21.4 million last year. Revenue for this year is expected to be between $104 million and $112 million, compared to Wall Street's estimate of $115.7 million.
Akoya Biosciences Sinks Over 30% in Late-Hours Activity Monday as Q1 Sales Miss Capital IQ Estimate
03:45 AM EDT, 05/14/2024 (MT Newswires) -- Akoya Biosciences Sinks Over 30% in Late-Hours Activity Monday as Q1 Sales Miss Capital IQ Estimate Price: 2.8500, Change: -1.27, Percent Change: -30.83
Stocks to Watch: Akoya Biosciences, Harrow, Augmedix
By Ben Glickman Akoya Biosciences said that first-quarter results fell short of expectations because of pressure on capital expenditures, deferred revenue at a pharmaceutical partner's lab and issues
Shares of Akoya Biosciences Drop After 1Q Earnings, Revenue Outlook Miss
By Adam L. Cataldo Shares of Akoya Biosciences tumbled after the spatial biology company's first-quarter results and its outlook for revenue this year fell short of analysts' estimates. The stock dr
INFN, VYGR and AMSC Are Among After Hour Movers
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million. Harrow (NASDAQ
Analysis
Price Target
No Data
